Ogawa T, Suda Y, Kashihara W, Hayashi T, Shimoyama T, Kusumoto S, Tamura T
Department of Oral Microbiology, Faculty of Dentistry, Osaka University, Japan.
Vaccine. 1997 Oct;15(15):1598-605. doi: 10.1016/s0264-410x(97)00102-3.
Helicobacter pylori lipid A, characterised by a glucosamine beta (1-6) disaccharide 1-(2-aminoethyl)phosphate acylated by (R)-3-hydroxyoctadecanoic acid and (R)-3-(octadecanoyloxy)octadecanoic acid at the 2- and 2'-positions, respectively, exhibited no or very low endotoxic activities, i.e. lethal toxicity in galactosamine-loaded mice, pyrogenicity for rabbits and the activity of the Limulus test compared with Escherichia coli-type synthetic lipid A (compound 506), which possesses beta-(1-6)-linked glucosamine disaccharide 1,4'-bisphosphate, with two acyloxyacyl groups at the 2'- and 3'-positions and two 3-hydroxytetradecanoyl groups at the 2- and 3-positions. The endotoxic properties of H. pylori lipid A were also a little weaker than those of the low endotoxic lipid A of P. gingivalis, which has 1-phospho beta-(1-6)-linked glucosamine disaccharide with 3-hydroxy-15-methylhexadecanoyl and 3-hexadecanoyloxy-15-methylhexadecanoyl groups at the 2- and 2'-positions, respectively. Further, the mitogenic activity of H. pylori lipid A in murine splenic mononuclear cells was also less than those of P. gingivalis lipid A and compound 506. However, H. pylori lipid A induced comparable production of interleukin-6 (IL-6) by human peripheral blood mononuclear cells (PBMC) compared with P. gingivalis lipid A and compound 506. H. pylori lipid A also increased human natural killer cell activity, and strongly agglutinated rabbit erythrocytes. However, the lipid As of H. pylori and P. gingivalis showed lower activities in inducing tumour necrosis factor alpha (TNF-alpha) production by human PBMC and IL-8 production by human gingival fibroblasts than that of compound 506. The structural feature of H. pylori lipid A may be associated with low endotoxic properties and potent immunobiological activities.
幽门螺杆菌脂多糖 A 的特征在于其氨基葡萄糖β(1-6)二糖 1-(2-氨基乙基)磷酸酯分别在 2 位和 2'位被(R)-3-羟基十八烷酸和(R)-3-(十八烷酰氧基)十八烷酸酰化,与具有β-(1-6)-连接的氨基葡萄糖二糖 1,4'-双磷酸酯、在 2'位和 3'位有两个酰氧基酰基以及在 2 位和 3 位有两个 3-羟基十四烷酰基的大肠杆菌型合成脂多糖 A(化合物 506)相比,其内毒素活性极低或几乎没有,即在半乳糖胺负荷小鼠中的致死毒性、对兔子的致热原性以及鲎试剂检测的活性。幽门螺杆菌脂多糖 A 的内毒素特性也比牙龈卟啉单胞菌的低内毒素脂多糖 A 略弱,牙龈卟啉单胞菌的脂多糖 A 在 2 位和 2'位分别具有 1-磷酸β-(1-6)-连接的氨基葡萄糖二糖以及 3-羟基-15-甲基十六烷酰基和 3-十六烷酰氧基-15-甲基十六烷酰基。此外,幽门螺杆菌脂多糖 A 在小鼠脾单核细胞中的促有丝分裂活性也低于牙龈卟啉单胞菌脂多糖 A 和化合物 506。然而,与牙龈卟啉单胞菌脂多糖 A 和化合物 506 相比,幽门螺杆菌脂多糖 A 诱导人外周血单核细胞(PBMC)产生白细胞介素-6(IL-6)的量相当。幽门螺杆菌脂多糖 A 还增强了人自然杀伤细胞的活性,并强烈凝集兔红细胞。然而,幽门螺杆菌和牙龈卟啉单胞菌的脂多糖 A 在诱导人 PBMC 产生肿瘤坏死因子α(TNF-α)以及人牙龈成纤维细胞产生 IL-8 方面的活性低于化合物 506。幽门螺杆菌脂多糖 A 的结构特征可能与其低内毒素特性和强大的免疫生物学活性有关。